| Italy | Turkey | Austria | |
| Leiomyosarcoma Removal | from $14,500 | - | - |
No hidden fees – just official clinic prices. Pay at the clinic for Leiomyosarcoma Removal upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Leiomyosarcoma Removal and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Leiomyosarcoma Removal journey.
Day 1
Day 2
Day 3
Day 4
Day 5 and 6
Day 7
Week 2 to 4
Week 5 to 8
Please note that each patient"s recovery timeline and experience may vary based on individual factors, including the extent of the tumor and overall health.
Prof. Filippini focuses on advanced oncological surgery, with over 46 years of experience of expertise in treating locally advanced tumors and multi-organ resections.
The doctor is a distinguished general surgeon with a specialization in Oncology and General Surgery, boasting 35 years of experience. The primary focus is on minimally invasive colorectal surgeries, proctological, and pelvic floor surgery. An active researcher and prolific author, the doctor participates in numerous healthcare projects related to colorectal cancer surgeries.
Graduating with distinction in Medicine and Surgery from the University of Rome 'La Sapienza', the doctor further specialized in General Surgery and Colorectal Surgery at prestigious institutions.
Italy hosts world-class oncology hubs specializing in leiomyosarcoma removal, particularly within Milan's dense medical corridor. Top-rated facilities like Istituto Nazionale dei Tumori and the European Institute of Oncology (IEO) lead the way in surgical volume, multidisciplinary rare tumor care, and robotic-assisted tumor resection.
Bookimed Expert Insight: While Milan is the primary sarcoma hub, surgeons like Prof. Arnaldo Filippini at Maria Cecilia Hospital bring elite US-based training from Memorial Sloan Kettering to Italy. This creates a high-quality alternative for multi-organ resections outside the busiest Milanese centers.
Patient Consensus: Seeking centers handling over 50 cases yearly is vital for success. Many recommend northern hubs like Milan over Rome for complex pelvic leiomyosarcoma care.
Standard surgical treatment for leiomyosarcoma in Italy focuses on radical en bloc resection with negative margins. Italian guidelines prioritize treatment at specialized sarcoma referral centers. For uterine cases, total abdominal hysterectomy is the gold standard without morcellation. Soft tissue cases require wide local excision with clear margins.
Bookimed Expert Insight: Italian surgical expertise often combines oncological resection with advanced reconstruction. Surgeons like Prof. Arnaldo Filippini at Maria Cecilia Hospital bring specialized training from Memorial Sloan Kettering to Italy. This international training influence means patients often access multi-organ resection techniques and microsurgery. These advanced approaches are vital for complex tumors in the retroperitoneum where organ involvement is high.
Patient Consensus: Patients emphasize the importance of contacting major oncology institutes in Rome or Milan directly. Many suggest seeking a second opinion within European networks to verify specific multimodal treatment protocols.
Patients undergoing complete leiomyosarcoma removal in Italy can expect a 5-year survival rate of approximately 60% to 75% for localized tumors. Survival heavily depends on tumor size, grade, and achieving clear margins during resection by experienced oncological surgeons using advanced surgical techniques.
Bookimed Expert Insight: Italian surgical expertise in sarcomas often links to multidisciplinary centers that combine reconstruction with removal. Prof. Arnaldo Filippini at Maria Cecilia Hospital trained at Memorial Sloan Kettering, bringing high-volume US experience to Italy. This specific focus on microsurgical and reconstructive techniques allows for more aggressive tumor removal while preserving patient function.
Recurrence surveillance in Italy follows European Society for Medical Oncology (ESMO) protocols at specialized sarcoma centers. High-grade leiomyosarcoma requires clinical visits and CT scans every 3–4 months for 3 years. Frequency transitions to every 6 months until year 5, followed by lifelong annual monitoring for late recurrences.
Bookimed Expert Insight: While local clinics offer standard scans, Italian sarcoma hubs like those in Rome or Milan prioritize multi-organ resection expertise. Surgeons like Prof. Arnaldo Filippini at Maria Cecilia Hospital bring experience from Memorial Sloan Kettering to manage complex recurrences. Patients should ensure their surveillance plan includes specialized imaging for retroperitoneal sites where recurrence is harder to detect.
Patient Consensus: Survivors emphasize tracking vague symptoms like fatigue or localized pain between scheduled scans. Many recommend using a symptoms app to provide data that might trigger earlier imaging if needed.
Italian oncology centers utilize robotic and minimally invasive techniques for localized leiomyosarcoma cases in high-volume referral centers. While open surgery remains the standard for large tumors, surgeons leverage Da Vinci robotic platforms and advanced laparoscopy for small, encapsulated tumors near major blood vessels or the retroperitoneum.
Bookimed Expert Insight: Data shows a high concentration of advanced technology in Rome and Ravenna. Clinics like Ospedale San Carlo di Nancy specialize in robotic systems, while experts like Prof. Arnaldo Filippini at Maria Cecilia Hospital bring international training from Memorial Sloan Kettering. This creates a unique environment where robotic dexterity meets multi-organ resection expertise.
Patient Consensus: Patients emphasize that while robotics are appealing, open surgery is often chosen for tumors larger than 10cm. They recommend prioritizing centers with specific sarcoma expertise to ensure long-term margin status and lower recurrence.